T. Rowe Price Associates’s Octave Specialty Group OSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$728K Buy
116,612
+14,647
+14% +$76.3K ﹤0.01% 2454
2026
Q1
$475K Buy
101,965
+31,024
+44% +$178K ﹤0.01% 2481
2025
Q4
$552K Hold
70,941
﹤0.01% 2345
2025
Q3
$592K Buy
70,941
+18,736
+36% +$158K ﹤0.01% 2299
2025
Q2
$371K Buy
52,205
+3,332
+7% +$24.8K ﹤0.01% 2441
2025
Q1
$428K Buy
48,873
+2,038
+4% +$21.5K ﹤0.01% 2312
2024
Q4
$593K Buy
46,835
+7,042
+18% +$84.9K ﹤0.01% 2215
2024
Q3
$447K Buy
39,793
+415
+1% +$4.85K ﹤0.01% 2297
2024
Q2
$505K Buy
39,378
+973
+3% +$14.8K ﹤0.01% 2183
2024
Q1
$601K Buy
38,405
+1,861
+5% +$29.3K ﹤0.01% 2137
2023
Q4
$603K Buy
36,544
+849
+2% +$11.8K ﹤0.01% 2097
2023
Q3
$431K Buy
35,695
+1,180
+3% +$15.9K ﹤0.01% 2180
2023
Q2
$492K Buy
34,515
+446
+1% +$6.53K ﹤0.01% 2141
2023
Q1
$528K Sell
34,069
-4,090
-11% -$66.2K ﹤0.01% 2083
2022
Q4
$665K Sell
38,159
-5,736
-13% -$85.2K ﹤0.01% 1997
2022
Q3
$560K Buy
43,895
+835
+2% +$11.1K ﹤0.01% 2066
2022
Q2
$489K Sell
43,060
-2,345
-5% -$22.3K ﹤0.01% 2228
2022
Q1
$472K Buy
45,405
+931
+2% +$12.6K ﹤0.01% 2366
2021
Q4
$714K Buy
44,474
+2,000
+5% +$31.4K ﹤0.01% 2204
2021
Q3
$608K Buy
42,474
+233
+0.6% +$3.33K ﹤0.01% 2287
2021
Q2
$661K Sell
42,241
-7,067
-14% -$114K ﹤0.01% 2249
2021
Q1
$825K Buy
49,308
+41
+0.1% +$670 ﹤0.01% 2148
2020
Q4
$758K Buy
49,267
+27,294
+124% +$402K ﹤0.01% 2060
2020
Q3
$281K Sell
21,973
-6,100
-22% -$78.6K ﹤0.01% 2311
2020
Q2
$402K Buy
28,073
+118
+0.4% +$1.73K ﹤0.01% 2135
2020
Q1
$345K Buy
27,955
+300
+1% +$5.75K ﹤0.01% 2148
2019
Q4
$597K Buy
27,655
+1,791
+7% +$36.7K ﹤0.01% 2093
2019
Q3
$506K Buy
25,864
+9,218
+55% +$169K ﹤0.01% 2096
2019
Q2
$280K Buy
16,646
+134
+0.8% +$2.29K ﹤0.01% 2320
2019
Q1
$299K Buy
16,512
+100
+0.6% +$1.91K ﹤0.01% 2290
2018
Q4
$283K Buy
+16,412
New +$301K ﹤0.01% 2309
2017
Q4
Sell
-23,926
Closed -$413K 2565
2017
Q3
$413K Hold
23,926
﹤0.01% 2161
2017
Q2
$415K Buy
23,926
+4,400
+23% +$78.2K ﹤0.01% 2129
2017
Q1
$368K Buy
+19,526
New +$411K ﹤0.01% 2175
2016
Q3
Sell
-17,000
Closed -$280K 2527
2016
Q2
$280K Hold
17,000
﹤0.01% 2207
2016
Q1
$269K Sell
17,000
-3,800
-18% -$55K ﹤0.01% 2196
2015
Q4
$293K Buy
+20,800
New +$320K ﹤0.01% 2169

Other funds holding OSG

T. Rowe Price Associates's OSG Position: Q2 2026 in Review

T. Rowe Price Associates increased its Octave Specialty Group (OSG) stake by 14% in Q2 2026, buying an estimated $76.3K and bringing the position to 116,612 shares worth $728K. The position accounts for ﹤0.01% of the portfolio, ranked #2454.

T. Rowe Price Associates first reported a position in OSG in Q4 2015 and has held it in 37 quarters since. The position peaked at $825K in Q1 2021. 148 funds tracked by Wall St. Rank hold OSG as of Q2 2026.

  • T. Rowe Price Associates held 116,612 shares of Octave Specialty Group worth $728K as of Q2 2026.
  • T. Rowe Price Associates bought 14,647 Octave Specialty Group shares in Q2 2026, an estimated $76.3K.
  • Octave Specialty Group made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2454 holding.
  • T. Rowe Price Associates first reported a position in Octave Specialty Group in Q4 2015 and has held it in 37 quarters since.
  • T. Rowe Price Associates's Octave Specialty Group position peaked at $825K in Q1 2021.
  • 148 funds tracked by Wall St. Rank held Octave Specialty Group as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.